The Residual Risk Reduction Initiative

Your login
Your password
Confirm your password
Your email
I agree to receive the R3i newsletter
Yes No

Prof. Virgil Brown

Emory Univ. School of Medicine,
Decatur, GA, USA


Current position

1998 -	Chief of Medicine - Atlanta Veterans’ Affairs Medical Center, Emory University School of Medicine, Atlanta, Georgia, USA
1991 -	Charles Howard Candler Professor of Internal Medicine, Emory University, Atlanta, Georgia, USA

Past position

1987 - 1991	President of the Medlantic Research Foundation, Washington, USA
1978 - 1987	Joseph Lowe and Louis Price Professor of Medicine - Director of the Division of Arteriosclerosis and Metabolism, Mt. Sinai School of Medicine, New York, NY, USA
1970 - 1978	Assistant and Associate Professor of Medicine, Director of the Lipid Research Clinics, University of California San Diego, La Jolla, CA, USA
1966 - 1969	Clinical Associate - National Heart and Lung Institute (NIH), Bethesda, MD, USA

Scientific training

	Undergraduate degree in physics and chemistry - Emory University (Phi Beta Kappa)
	M.D. - Yale University (Alpha Omega Alpha), CT, USA
	Internal Medicine Residency, Johns Hopkins Hospital, Baltimore, MD, USA
	Fellowship in Endocrinology and Metabolism –Yale, New Haven Hospital, CT, USA

Professional Associations

1991 -1992	President of the National AHA
1998	Chairman of the Emory University Faculty Council President of the Senate of Emory University
1998 - 1999	President of the Southeast Lipid Association
2002 - 2004	President of the National Lipid Association
2007	President of the American Board of Clinical Lipidology President Elect of the International Atherosclerosis Society

Awards

1985	Humboldt Fellowship to study - University of Cologne, Germany
1987	Distinguished Professor of the Year (The Mt. Sinai Department of Medicine)
1996	“Gold Heart Award”, by the American Heart Association
1999	Master Physician Award, American College of Physicians
2000	Bruce Logue Award, Fulton County Heart Association

Research

While at the NIH, working with Drs. Donald Fredrickson and Robert Levy, he isolated and characterized for the first time three of the nine proteins involved in the structure of the plasma lipoproteins. This group of so called “C” apolipoproteins proved to be very important in regulating the levels of the blood triglycerides and cholesterol. As Director of Lipid Research Clinic at the University of California (San Diego, CA, USA), he continued research on the function of the lipoproteins in carrying cholesterol and triglycerides in the blood. He and his collaborators helped define the role of the lipase enzymes in breaking down triglycerides so that they could be removed from the blood stream by the various organs of the body. His studies also helped understand how various dietary changes and medications alter the metabolism of the lipoproteins to correct high levels of cholesterol. While in San Diego, he was one of the Principal Investigators of the Lipid Research Clinics Primary Prevention Trial which proved that cholesterol reduction prevented first heart attacks in hypercholesterolemic men (1984)